Skip to main content
. Author manuscript; available in PMC: 2009 Apr 15.
Published in final edited form as: Bioorg Med Chem Lett. 2008 Mar 18;18(8):2662–2668. doi: 10.1016/j.bmcl.2008.03.025

Table 3.

Cytotoxicity and selectivity assessment

Comp. CD50 (μM)a SIMtb
(CD50/IC50GAST-D)
SIYp
(CD50/IC50PMH-D)
1 3 <0.006 <0.3
2 5 <0.01 <1
3 5 <0.01 10
4 6 <0.02 15
5 5 <0.01 7
6 3 0.01 300
7 3 0.04 3
8 3 0.1 4
9 15 <0.03 8
10 1 0.04 1
11 17 0.6 9
12 11 0.4 14
13 42 14 <2
14 1 0.002 0.5
15 4 <0.008 6
16 21 0.7 7
17 3 0.007 3
18 13 <0.03 7
19 11 0.02 11
20 25 <0.05 42
21 15 0.1 5
22 16 <0.03 16
23 63 0.4 63
24 23 0.3 33
25 62 1.0 155
26 30 0.4 50
27 26 0.5 2
28 31 0.2 155
29 248 3 <3
30 19 0.8 <1
31 29 0.06 <0.8
32 398 50 <10
RIF 190 nd nd
STR >500 nd nd
CHX 0.1 nd nd
a

CD50s were calculated from sigmoidal curves fitted to triplicate sets of dose-response data. SIMtb and SIYp, selectivity index relative to activity against M. tuberculosis and Y. pestis, respectively. CD50 and SI values <1 and values >1 were rounded to one significant digit and to the nearest non-fractional number, respectively. CHX, cycloheximide. Other abbreviations as in Table 1.